Posted by Michael Wonder on 19 Apr 2019
China to list more cancer drugs for medical insurance coverage
18 April 2019 - China will include more anti-cancer drugs on its new list of medicines eligible for medical insurance reimbursement to be released this year.
Apart from cancer drugs, medicines for rare diseases, chronic illness, children and first-aid treatment are among the options for a lengthened reimbursement list, the National Healthcare Security Administration said in a document aimed at reducing the burden on patients.
The candidates for inclusion should be drugs that have been launched in markets with the approval of the National Medical Products Administration before 31 December 2018, said the document.
